Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title	Author(s)
	2017	Modulation of TRP channel activity by hydroxylation and its therapeutic potential	Nagarajan, Y.; Rychkov, G.; Peet, D.
	2017	Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives	Kumeria, T.; McInnes, S.; Maher, S.; Santos, A.
	2017	Advances in drug metabolism and pharmacogenetics research in Australia	Mackenzie, P.; Somogyi, A.; Miners, J.
	2016	Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia	Larance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.
	2016	Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users	McKetin, R.; Gardner, J.; Baker, A.; Dawe, S.; Ali, R.; Voce, A.; Leach, L.; Lubman, D.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 02 Nov 2016 : Sydney, Australia)
	2016	A quantitative review and meta-models of the variability and factors affecting oral drug absorption-Part II: gastrointestinal transit time	Abuhelwa, A.; Foster, D.; Upton, R.
	2016	Psychosocial interventions for cannabis use disorder	Gates, P.; Sabioni, P.; Copeland, J.; Le Foll, B.; Gowing, L.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 02 Nov 2016 : Sydney, Australia)
	2016	Psychosocial interventions for cannabis use disorder	Gates, P.; Sabioni, P.; Copeland, J.; Le Foll, B.; Gowing, L.
	2016	A quantitative review and meta-models of the variability and factors affecting oral drug absorption-Part I: gastrointestinal pH	Abuhelwa, A.; Foster, D.; Upton, R.
	2016	Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression	Loo, C.; Gálvez, V.; O'Keefe, E.; Mitchell, P.; Hadzi-Pavlovic, D.; Leyden, J.; Harper, S.; Somogyi, A.; Lai, R.; Weickert, C.; Glue, P.
	2016	A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors	Xiao, T.; Liu, R.; Proud, C.; Wang, M.
	2015	Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids	Peacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L.
	2015	Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation	Peacock, A.; Degenhardt, L.; Hordern, A.; Larance, B.; Cama, E.; White, N.; Kihas, I.; Bruno, R.
	2015	The characteristics of a cohort who tamper with prescribed and diverted opioid medications	Larance, B.; Lintzeris, N.; Bruno, R.; Peacock, A.; Cama, E.; Ali, R.; Kihas, I.; Hordern, A.; White, N.; Degenhardt, L.
	2015	A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone	Peacock, A.; Degenhardt, L.; Larance, B.; Cama, E.; Lintzeris, N.; Ali, R.; Bruno, R.
	2015	Wetlands and human health	Finlayson, C.M.; Horwitz, P.; Weinstein, P.
	2015	Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol	Degenhardt, L.; Larance, B.; Bruno, R.; Lintzeris, N.; Ali, R.; Farrell, M.
	2015	Pharmacogenetics of opioid response	Somogyi, A.; Coller, J.; Barratt, D.
	2015	Early social environment affects the endogenous oxytocin system: a review and future directions	Alves, E.; Fielder, A.; Ghabriel, N.; Sawyer, M.; Buisman-Pijlman, F.
	2015	Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague-Dawley and Dark Agouti rats	Licari, G.; Somogyi, A.; Milne, R.; Sallustio, B.